投资工具 / 美股
Steris · STE
数据仅供参考,不构成投资建议。
投资工具 / 美股
数据仅供参考,不构成投资建议。
| 季度 | 截止日 | 申报日 | 营收 | 营收同比 g | Δg | 推导方式 |
|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 2026-11-05 | $1.59B | +8.8% | +1.5pp | 3M |
| 2026Q2 | 2026-06-30 | 2026-08-07 | $1.49B | +7.3% | +0.0pp | 3M |
| 2026Q1 | 2026-03-31 | 2026-05-29 | $1.59B | +7.3% | −1.9pp | FY-9M |
| 2025Q4 | 2025-12-31 | 2026-02-06 | $1.5B | +9.2% | −0.7pp | 3M |
| 2025Q3 | 2025-09-30 | 2026-11-05 | $1.46B | +9.9% | +1.2pp | 3M |
| 2025Q2 | 2025-06-30 | 2026-08-07 | $1.39B | +8.7% | +4.4pp | 3M |
| 2025Q1 | 2025-03-31 | 2026-05-29 | $1.48B | +4.3% | −1.3pp | FY-9M |
| 2024Q4 | 2024-12-31 | 2026-02-06 | $1.37B | +5.6% | −1.7pp | 3M |
口径:单季同比;Δg = 本季 g − 上季 g;按财季映射日历季度;申报日可见。† 不连续点(上年同季营收 ≤0 或 Δg 幅度超过 50pp)。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 季度 | 截止日 | 毛利 | 销货成本 | 毛利率 | 环比 | 同比 | Δ² |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $710.8M | $877.8M | 44.7% | −109bp | +51bp | −18bp |
| 2026Q2 | 2026-06-30 | $684.2M | $808.6M | 45.8% | +195bp | +69bp | +12bp |
| 季度 | 截止日 | 合同负债 | CL g | RPO | RPO g | 账单额 | 账单额 g | RPO 覆盖 |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $61.8M | +24.8% | $1.54B | −20.3% | $1.59B | +9.0% | 0.2× |
| 2026Q2 | 2026-06-30 | $61.1M | +18.0% | $1.54B |
| 季度 | 截止日 | OCF TTM | OCF g | CapEx TTM | CapEx g | FCF TTM | CapEx 密度 | SBC/FCF | SBC/Rev |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $1.29B | −0.9% | $352.5M | +3.6% | $937.2M | 5.7% | 6.7% | 1.0% |
| 2026Q2 | 2026-06-30 | $1.29B |
| 季度 | 截止日 | 存货 | 存货 g | 营收 g | 剪刀差 | DIO | DIO 同比 |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $737M | +11.9% | +8.8% | +3.1pp | 76.6 | +2.8 |
| 2026Q2 | 2026-06-30 | $712.1M | +11.1% | +7.3% | +3.8pp | 80.4 |
| 交易日 | 申报日 | 申报人 | 头衔 | 代码 | 股数 | 价格 | 金额 | 10b5-1 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-11 | 2026-11-12 | Burton Karen L | Sr. Vice Pres., CFO | S | 5,880 | $255.62 | $1.5M | |
口径:修正广度 =(近 30 日上调 − 下调)/(上调 + 下调),样本 < 3 不出;只展示衍生指标,不展示一致预期原值。 · 数据截至 2026-11-16 · 来源:Yahoo Finance / Nasdaq
未覆盖(期权覆盖为 S&P 500 期权持仓前 100 名每日、其余每周轮换)
口径:本股的警报事件历史(含基线);事件保留 90 天。
| 2026Q1 | 2026-03-31 | $697.1M | $891.2M | 43.9% | +8bp | +58bp | +129bp |
| 2025Q4 | 2025-12-31 | $655.5M | $840.7M | 43.8% | −42bp | −72bp | −139bp |
| 2025Q3 | 2025-09-30 | $645.9M | $814.4M | 44.2% | −91bp | +68bp | +27bp |
| 2025Q2 | 2025-06-30 | $628M | $763.1M | 45.1% | +183bp | +41bp | −183bp |
| 2025Q1 | 2025-03-31 | $641.2M | $839.4M | 43.3% | −122bp | +224bp | +87bp |
| 2024Q4 | 2024-12-31 | $610.3M | $760.2M | 44.5% | +97bp | +137bp | +193bp |
口径:GM = 毛利/营收;毛利缺失时用 营收−销货成本 推导;环比/同比为基点。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| −15.5% |
| $1.49B |
| +7.9% |
| 0.3× |
| 2026Q1 | 2026-03-31 | $59.1M | +2.8% | $1.37B | −17.6% | $1.59B | +9.0% | 0.2× |
| 2025Q4 | 2025-12-31 | $58.8M | −26.5% | $1.89B | +12.8% | $1.51B | +9.3% | 0.3× |
| 2025Q3 | 2025-09-30 | $49.5M | −31.9% | $1.93B | +18.4% | $1.46B | +9.4% | 0.3× |
| 2025Q2 | 2025-06-30 | $51.8M | −25.3% | $1.82B | +21.6% | $1.39B | +8.4% | 0.3× |
| 2025Q1 | 2025-03-31 | $57.5M | −18.4% | $1.66B | +16.8% | $1.46B | +4.2% | 0.3× |
| 2024Q4 | 2024-12-31 | $80.03M | −11.4% | $1.68B | +7.7% | $1.38B | +6.4% | 0.3× |
口径:g = 同比;账单额 = 营收 + Δ合同负债(同口径);RPO 覆盖 = RPO / TTM 营收。跨口径(总额/仅流动)不比较。 合同负债口径: 总额 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +1.9% |
| $362.9M |
| +2.1% |
| $925.6M |
| 6.0% |
| 6.8% |
| 1.0% |
| 2026Q1 | 2026-03-31 | $1.34B | +16.8% | $369M | −0.3% | $972.4M | 6.2% | 6.3% | 1.0% |
| 2025Q4 | 2025-12-31 | $1.27B | +10.9% | $349.7M | −10.5% | $917.1M | 6.0% | 6.4% | 1.0% |
| 2025Q3 | 2025-09-30 | $1.3B | +18.2% | $340.2M | −19.1% | $961.2M | 6.0% | 6.1% | 1.0% |
| 2025Q2 | 2025-06-30 | $1.26B | +27.0% | $355.6M | −11.5% | $908.8M | 6.4% | 6.4% | 1.0% |
| 2025Q1 | 2025-03-31 | $1.15B | +18.0% | $370.1M | +2.7% | $778M | 6.8% | 7.4% | 1.1% |
| 2024Q4 | 2024-12-31 | $1.14B | +22.2% | $390.67M | +14.8% | $751.46M | 7.2% | 7.5% | 1.0% |
口径:TTM = 近四个离散单季之和;FCF = OCF − CapEx;CapEx 密度 = CapEx/营收 TTM;FCF≤0 时 SBC/FCF 不计算。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +3.7 |
| 2026Q1 | 2026-03-31 | $631.8M | +8.7% | +7.3% | +1.4pp | 64.7 | +1.5 |
| 2025Q4 | 2025-12-31 | $673.5M | +3.7% | +9.2% | −5.5pp | 73.1 | −4.9 |
| 2025Q3 | 2025-09-30 | $658.5M | −4.4% | +9.9% | −14.3pp | 73.8 | −10.0 |
| 2025Q2 | 2025-06-30 | $641.2M | −8.2% | +8.7% | −16.9pp | 76.7 | −13.5 |
| 2025Q1 | 2025-03-31 | $581.3M | −13.8% | +4.3% | −18.1pp | 63.2 | −10.4 |
| 2024Q4 | 2024-12-31 | $649.56M | −24.1% | +5.6% | −29.7pp | 78.0 | −27.9 |
口径:剪刀差 = 存货同比 − 营收同比(pp,正值=存货增速快于营收);DIO = 存货/销货成本 × 91.25 天。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 2026-11-10 |
| 2026-11-12 |
| Sohi Mohsen |
| — |
| S |
| 1,665 |
| $253.90 |
| $422.74K |
| 2026-11-10 | 2026-11-12 | Sohi Mohsen | — | S | 3,228 | $252.87 | $816.26K |
| 2026-08-12 | 2026-08-12 | Sohi Mohsen | — | S | 4,058 | $235.78 | $956.8K |
| 2026-06-15 | 2026-06-16 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | S | 1,419 | $209.28 | $296.97K | ✓ |
| 2026-06-05 | 2026-06-08 | Carestio Daniel A | President and CEO | S | 1,374 | $212.00 | $291.29K | ✓ |
| 2026-06-04 | 2026-06-08 | Carestio Daniel A | President and CEO | S | 3,054 | $214.64 | $655.51K | ✓ |
| 2026-06-02 | 2026-06-04 | Breeden Richard C | — | S | 1,481 | $209.51 | $310.28K |
| 2026-03-05 | 2026-03-06 | FELDMANN CYNTHIA L | — | S | 3,098 | $237.21 | $734.88K |
| 2025-11-21 | 2025-11-25 | Madsen Julia | Sr. VP and GM, Life Sciences | S | 2,872 | $262.00 | $752.46K |
| 2025-11-21 | 2025-11-25 | Madsen Julia | Sr. VP and GM, Life Sciences | S | 2,136 | $262.00 | $559.63K |
| 2025-11-18 | 2025-11-20 | Tamaro Renato | V.P. & Corporate Treasurer | S | 1,500 | $257.76 | $386.64K |
| 2025-11-18 | 2025-11-20 | Tamaro Renato | V.P. & Corporate Treasurer | S | 3,324 | $257.43 | $855.7K |
| 2025-11-18 | 2025-11-20 | Tamaro Renato | V.P. & Corporate Treasurer | S | 212 | $258.03 | $54.7K |
| 2025-11-11 | 2025-11-13 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | S | 15,000 | $265.14 | $3.98M |
| 2025-10-06 | 2025-10-08 | Carestio Daniel A | President and CEO | S | 159 | $241.82 | $38.45K | ✓ |
| 2025-08-20 | 2025-08-22 | Tamaro Renato | V.P. & Corporate Treasurer | S | 3,204 | $249.24 | $798.56K |
| 2025-08-11 | 2025-08-12 | Sohi Mohsen | — | S | 4,110 | $241.96 | $994.46K |
| 2025-08-11 | 2025-08-12 | FELDMANN CYNTHIA L | — | S | 3,495 | $241.56 | $844.25K |
| 2025-08-11 | 2025-08-12 | Burton Karen L | VP & CAO | S | 7,900 | $241.73 | $1.91M |
| 2025-06-13 | 2025-06-17 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | S | 330 | $240.63 | $79.41K | ✓ |
| 2025-06-13 | 2025-06-17 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | S | 1,648 | $241.61 | $398.17K | ✓ |
| 2025-06-05 | 2025-06-06 | Carestio Daniel A | President and CEO | S | 4,980 | $242.67 | $1.21M | ✓ |
| 2025-06-05 | 2025-06-06 | Carestio Daniel A | President and CEO | S | 5,126 | $243.49 | $1.25M | ✓ |
| 2025-06-05 | 2025-06-06 | Carestio Daniel A | President and CEO | S | 7,520 | $241.85 | $1.82M | ✓ |
| 2025-05-20 | 2025-05-22 | Majors Cary L | SVP and President, Healthcare | S | 8,247 | $249.73 | $2.06M |
| 2025-05-20 | 2025-05-22 | Majors Cary L | SVP and President, Healthcare | S | 4,581 | $250.71 | $1.15M |
| 2024-11-25 | 2024-11-27 | Majors Cary L | SVP and President, Healthcare | S | 1,682 | $217.32 | $365.53K |
口径:Form 4/4A 公开市场买入(P)与卖出(S),申报人为董事或高管;汇总与集群为近 365 天,明细为最近 40 笔。 · 数据截至 2026-11-16 · 来源:SEC EDGAR Form 4
口径:SI 来自 FINRA(双周结算);SI% 分母 = SEC 封面总股本;借券费为 IBKR 报价(非全市场);卖空占比 = 当日卖空量/总成交量。 · 数据截至 SI 2026-10-30 · Reg SHO 2026-11-16 · 借券 2026-11-11 · 沿用上一版 · 来源:FINRA、IBKR、iBorrowDesk